Hooray!
- Merck Cervical Cancer Vaccine Wins Backing From U.S. Advisers
The U.S. FDA advisory panel endorsed the approval of Merck’s new genital warts vaccine. Now, only if there was a vaccine for the dreaded herpes.
RSS feed for comments on this post · TrackBack URL
